Edition V17N02 | Year 2012 | Editorial Original Article | Pages 90 to 96
Eduardo Rollo Duarte , Maria Luiza M. A. Frigério , Orivaldo Tavano , Paulo César Razuk , Maria Rita De Cássia M. Costa , Carlos Henrique Ferreira Martins , Maurício Serejo Ribeiro , Éderson A. G.Betiol
Introduction: Among the sleep disorders reported by the American Academy of Sleep, the most common is obstructive sleep apnea-hypopnea syndrome (OSAHS), which is caused by difficulties in air passage and complete interruption of air flow in the airway. This syndrome is associated with increased morbidity and mortality in apneic individuals. Objective: It was the objective of this paper to evaluate a removable mandibular advancement device as it provides a noninvasive, straightforward treatment readily accepted by patients. Methods: In this study, 15 patients without temporomandibular disorders (TMD) and with excessive daytime sleepiness or snoring were evaluated. Data were collected by means of: Polysomnography before and after placement of an intraoral appliance, analysis of TMD signs and symptoms using a patient history questionnaire, muscle and TMJ palpation. Results: After treatment, the statistical analysis (t-test, and the ?before and after? test) showed a mean reduction of 77.6% (p=0.001) in the apnea-hypopnea index, an increase in lowest oxyhemoglobin saturation (p=0.05), decrease in desaturation (p=0.05), decrease in micro-awakenings or EEG arousals (p=0.05) and highly significant improvement in daytime sleepiness (p=0.005), measured by the Epworth Sleepiness Scale. No TMD appeared during the monitoring period. Conclusion: The oral device developed in this study was considered effective for mild to moderate OSAHS.